NEW YORK, Oct. 31, 2025 /PRNewswire/ — Metsera, Inc. (NASDAQ: MTSR) (“Metsera” or the “Company”) today issued the following statement in response to litigation filed against the Company by Pfizer: “Metsera disagrees with the allegations […]
#Rosal Top Picks
Recent Posts
- Празднование инноваций,
- NEW YORK, Nov. 2, 2025 /PRNewswire/ —
- TAIPEI, 2 novembre 2025 /PRNewswire/ —
- TAIPEI, 2 de noviembre de 2025 /PRNewswire/
- LONDON, Nov. 1, 2025 /PRNewswire/ — Travelzoo®